ROPINIROLE HYDROCHLORIDE | A090135 | GLENMARK PHARMACEUTICALS LTD
Highest NADAC/Unit
$0.0824
per ea
Lowest NADAC/Unit
$0.0431
per ea
Brand NDCs
0
Generic NDCs
7
| NDC Description | NADAC/Unit | Unit | Type | Generic NADAC | Effective |
|---|---|---|---|---|---|
| 68462025901ROPINIROLE HCL 5 MG TABLET | $0.0824 | EA | Generic | — | 2026-10-21 |
| 68462025801ROPINIROLE HCL 4 MG TABLET | $0.0815 | EA | Generic | — | 2026-10-21 |
| 68462025701ROPINIROLE HCL 3 MG TABLET | $0.0793 | EA | Generic | — | 2026-10-21 |
| 68462025601ROPINIROLE HCL 2 MG TABLET | $0.0631 | EA | Generic | — | 2026-10-21 |
| 68462025501ROPINIROLE HCL 1 MG TABLET | $0.0461 | EA | Generic | — | 2026-10-21 |
| 68462025301ROPINIROLE HCL 0.25 MG TABLET | $0.0444 | EA | Generic | — | 2026-10-21 |
| 68462025401ROPINIROLE HCL 0.5 MG TABLET | $0.0431 | EA | Generic | — | 2026-10-21 |
Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.
No patent or exclusivity listings for this strength.